Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02YQO
|
||||
Former ID |
DNC004411
|
||||
Drug Name |
SCH-442416
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
Download2D MOL |
||||
Formula |
C20H19N7O2
|
||||
InChI |
InChI=1S/C20H19N7O2/c1-28-14-8-6-13(7-9-14)4-2-10-26-18-15(12-22-26)19-23-17(16-5-3-11-29-16)25-27(19)20(21)24-18/h3,5-9,11-12H,2,4,10H2,1H3,(H2,21,24)
|
||||
InChIKey |
AEULVFLPCJOBCE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
15700772, 22957973, 29215552, 40960041, 77737929, 85787661, 103375076, 103991936, 127396092, 134223394, 134341616, 135697652, 160830068, 162023455, 162223704, 163094382, 163394401, 163842836, 172873496, 178100324, 189614611, 204418666, 223532855, 227238107, 241070384, 249492309, 249820076, 252156533, 252160006, 252216283
|
||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [531130] | |
Adenosine A2a receptor | Target Info | Inhibitor | [525917] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [525917] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
References | |||||
Ref 522117 | ClinicalTrials.gov (NCT00531193) Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers. U.S. National Institutes of Health. | ||||
Ref 540246 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3283). | ||||
Ref 525917 | J Med Chem. 2000 Nov 16;43(23):4359-62.Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography. | ||||
Ref 531130 | Bioorg Med Chem Lett. 2010 Oct 1;20(19):5690-4. Epub 2010 Aug 10.Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.